These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Phagocytic polymorphonuclear function in patients with progressive uremia and the effect of acute hemodialysis. Mahajan S; Kalra OP; Asit KT; Ahuja G; Kalra V Ren Fail; 2005; 27(4):357-60. PubMed ID: 16060119 [TBL] [Abstract][Full Text] [Related]
23. A dramatic reduction of normalized protein catabolic rate occurs late in the course of progressive renal insufficiency. Chandna SM; Kulinskaya E; Farrington K Nephrol Dial Transplant; 2005 Oct; 20(10):2130-8. PubMed ID: 15956057 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of toxic metals in blood and urine samples of chronic renal failure patients, before and after dialysis. Kazi TG; Jalbani N; Kazi N; Jamali MK; Arain MB; Afridi HI; Kandhro A; Pirzado Z Ren Fail; 2008; 30(7):737-45. PubMed ID: 18704823 [TBL] [Abstract][Full Text] [Related]
25. Is off-pump revascularization better for patients with non-dialysis-dependent renal insufficiency? Beauford RB; Saunders CR; Niemeier LA; Lunceford TA; Karanam R; Prendergast T; Shah S; Burns P; Sardari F; Goldstein DJ Heart Surg Forum; 2004 Apr; 7(2):E141-6. PubMed ID: 15138092 [TBL] [Abstract][Full Text] [Related]
26. Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology? Busch M; Fleck C; Wolf G; Stein G Amino Acids; 2006 May; 30(3):225-32. PubMed ID: 16680555 [TBL] [Abstract][Full Text] [Related]
27. Selenium, lead, and cadmium levels in renal failure patients in China. Chen B; Lamberts LV; Behets GJ; Zhao T; Zhou M; Liu G; Hou X; Guan G; D'Haese PC Biol Trace Elem Res; 2009 Oct; 131(1):1-12. PubMed ID: 19266172 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria. Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R; Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073 [TBL] [Abstract][Full Text] [Related]
29. [Clinical aspects and renal function in patients with endemic nephropathy]. Bukvić D; Djukanović L; Janković S Srp Arh Celok Lek; 2003; 131(1-2):10-6. PubMed ID: 14608855 [TBL] [Abstract][Full Text] [Related]
30. Comparison of combined urea and creatinine clearance and prediction equations as measures of residual renal function when GFR is low. Almond A; Siddiqui S; Robertson S; Norrie J; Isles C QJM; 2008 Aug; 101(8):619-24. PubMed ID: 18540009 [TBL] [Abstract][Full Text] [Related]
31. Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. Cheung AK; Rocco MV; Yan G; Leypoldt JK; Levin NW; Greene T; Agodoa L; Bailey J; Beck GJ; Clark W; Levey AS; Ornt DB; Schulman G; Schwab S; Teehan B; Eknoyan G J Am Soc Nephrol; 2006 Feb; 17(2):546-55. PubMed ID: 16382021 [TBL] [Abstract][Full Text] [Related]
35. Serum cystatin C: a surrogate marker for the characteristics of peritoneal membrane in dialysis patients. Al-Wakeel JS; Hammad D; Memon NA; Tarif N; Shah I; Chaudhary A Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):227-31. PubMed ID: 19237809 [TBL] [Abstract][Full Text] [Related]
36. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Siu YP; Leung KT; Tong MK; Kwan TH Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385 [TBL] [Abstract][Full Text] [Related]